Possible clinical significance of serum soluble interleukin-2 receptor level in primary bone lymphoma

Two case reports

Hiroki Yabe, Hironori Ueno, Kensuke Ochi, Hideo Morioka, Hiroo Yabe, Chihiro Terai

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In two patients with primary bone lymphoma (PBL) treated in our clinic, serum levels of soluble interleukin-2 receptor (sIL-2R) reflected the clinical course. In both cases, sIL-2R levels were high before treatment and normalized with the therapeutic effects of chemotherapy, coinciding with the changes in lactate dehydrogenase levels and radiographic findings. Adding to the recently reported results of the diagnostic ability of sIL-2R in PBL, our case study highlights the clinical significance of serum sIL-2R levels as a tumor marker in PBL cases.

Original languageEnglish
Pages (from-to)125-131
Number of pages7
JournalCase Reports in Oncology
Volume4
Issue number1
DOIs
Publication statusPublished - 2011 Jan

Fingerprint

Interleukin-2 Receptors
Lymphoma
Bone and Bones
Serum
Therapeutic Uses
Tumor Biomarkers
L-Lactate Dehydrogenase
Drug Therapy
Therapeutics

Keywords

  • PBL
  • Primary bone lymphoma
  • sIL-2R
  • Soluble interleukin-2 receptor
  • Tumor marker

ASJC Scopus subject areas

  • Oncology

Cite this

Possible clinical significance of serum soluble interleukin-2 receptor level in primary bone lymphoma : Two case reports. / Yabe, Hiroki; Ueno, Hironori; Ochi, Kensuke; Morioka, Hideo; Yabe, Hiroo; Terai, Chihiro.

In: Case Reports in Oncology, Vol. 4, No. 1, 01.2011, p. 125-131.

Research output: Contribution to journalArticle

Yabe, Hiroki ; Ueno, Hironori ; Ochi, Kensuke ; Morioka, Hideo ; Yabe, Hiroo ; Terai, Chihiro. / Possible clinical significance of serum soluble interleukin-2 receptor level in primary bone lymphoma : Two case reports. In: Case Reports in Oncology. 2011 ; Vol. 4, No. 1. pp. 125-131.
@article{c3e1a01efed54e9d8079faae934bc303,
title = "Possible clinical significance of serum soluble interleukin-2 receptor level in primary bone lymphoma: Two case reports",
abstract = "In two patients with primary bone lymphoma (PBL) treated in our clinic, serum levels of soluble interleukin-2 receptor (sIL-2R) reflected the clinical course. In both cases, sIL-2R levels were high before treatment and normalized with the therapeutic effects of chemotherapy, coinciding with the changes in lactate dehydrogenase levels and radiographic findings. Adding to the recently reported results of the diagnostic ability of sIL-2R in PBL, our case study highlights the clinical significance of serum sIL-2R levels as a tumor marker in PBL cases.",
keywords = "PBL, Primary bone lymphoma, sIL-2R, Soluble interleukin-2 receptor, Tumor marker",
author = "Hiroki Yabe and Hironori Ueno and Kensuke Ochi and Hideo Morioka and Hiroo Yabe and Chihiro Terai",
year = "2011",
month = "1",
doi = "10.1159/000325399",
language = "English",
volume = "4",
pages = "125--131",
journal = "Case Reports in Oncology",
issn = "1662-6575",
number = "1",

}

TY - JOUR

T1 - Possible clinical significance of serum soluble interleukin-2 receptor level in primary bone lymphoma

T2 - Two case reports

AU - Yabe, Hiroki

AU - Ueno, Hironori

AU - Ochi, Kensuke

AU - Morioka, Hideo

AU - Yabe, Hiroo

AU - Terai, Chihiro

PY - 2011/1

Y1 - 2011/1

N2 - In two patients with primary bone lymphoma (PBL) treated in our clinic, serum levels of soluble interleukin-2 receptor (sIL-2R) reflected the clinical course. In both cases, sIL-2R levels were high before treatment and normalized with the therapeutic effects of chemotherapy, coinciding with the changes in lactate dehydrogenase levels and radiographic findings. Adding to the recently reported results of the diagnostic ability of sIL-2R in PBL, our case study highlights the clinical significance of serum sIL-2R levels as a tumor marker in PBL cases.

AB - In two patients with primary bone lymphoma (PBL) treated in our clinic, serum levels of soluble interleukin-2 receptor (sIL-2R) reflected the clinical course. In both cases, sIL-2R levels were high before treatment and normalized with the therapeutic effects of chemotherapy, coinciding with the changes in lactate dehydrogenase levels and radiographic findings. Adding to the recently reported results of the diagnostic ability of sIL-2R in PBL, our case study highlights the clinical significance of serum sIL-2R levels as a tumor marker in PBL cases.

KW - PBL

KW - Primary bone lymphoma

KW - sIL-2R

KW - Soluble interleukin-2 receptor

KW - Tumor marker

UR - http://www.scopus.com/inward/record.url?scp=79957623328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957623328&partnerID=8YFLogxK

U2 - 10.1159/000325399

DO - 10.1159/000325399

M3 - Article

VL - 4

SP - 125

EP - 131

JO - Case Reports in Oncology

JF - Case Reports in Oncology

SN - 1662-6575

IS - 1

ER -